Cholesterol lowering compounds produced by directed biosynthesis
US5302604A · kind A · utility
16Cited by
3References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 6, 1992 |
| Grant date | Apr 12, 1994 |
| Priority date | — |
| Expiry date | Oct 6, 2012 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K45/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of Structural Formula (I) ##STR1## are produced by directed biosynthesis. These compounds are squalene synthetase inhibitors and thus useful as cholesterol lowering agents, antifungal agents and cancer treatment agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.